The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs

Ali Yazdanyar1, Anne B Newman

  • 1Center for Aging and Population Health, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 130 North Bellefield Avenue, Pittsburgh, PA 15213, USA.

Insights

Cardiovascular disease (CVD) significantly impacts older Americans, causing mortality and high costs. Prevention efforts are crucial for successful aging and extending healthy life years.

Area of Science:

  • Gerontology
  • Epidemiology
  • Cardiology

Background:

  • Cardiovascular disease (CVD) presents a substantial challenge to the health and well-being of older Americans.
  • The aging population will exacerbate the societal burden of CVD, increasing mortality, morbidity, and healthcare expenditures.
  • Effective CVD prevention strategies are essential for promoting successful aging and enhancing functional longevity.

Purpose of the Study:

  • To provide a comprehensive overview of cardiovascular disease epidemiology in older adults.
  • To assess the multifaceted impact of CVD on mortality, morbidity, disability, and functional decline in the elderly population.
  • To highlight the economic implications of CVD in older Americans, focusing on healthcare costs.

Main Methods:

  • Epidemiological data analysis focusing on the older adult demographic.
  • Review of existing literature on CVD prevalence and incidence in seniors.
  • Assessment of mortality, morbidity, and disability statistics related to CVD in this age group.

Main Results:

  • Cardiovascular disease is a leading cause of death and disability among older Americans.
  • CVD significantly contributes to functional decline and reduced quality of life in the elderly.
  • The economic burden of CVD in older adults is substantial, driven by extensive healthcare utilization and costs.

Conclusions:

  • Addressing cardiovascular disease is critical for improving health outcomes in the growing older adult population.
  • Expanded CVD prevention initiatives offer a significant opportunity to foster successful aging and increase healthspan.
  • Understanding the epidemiology of CVD in older adults is fundamental for developing targeted public health interventions and healthcare policies.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...